Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–30.
Article
PubMed
Google Scholar
Chizuka A, Suda M, Shibata T, et al. Difference between hematological malignancy and solid tumor research articles published in four major medical journals. Leukemia. 2006;20:1655–7.
CAS
Article
Google Scholar
Avritscher EB, Cooksley CD, Rolston KV, et al. Serious postoperative infections following resection of common solid tumors: outcomes, costs, and impact of hospital surgical volume. Support Care Cancer. 2014;22:527–35.
Article
PubMed
Google Scholar
Gudiol C, Aguado JM, Carratalà J. Bloodstream infections in patients with solid tumors. Virulence. 2016;7:298–308.
CAS
Article
PubMed
PubMed Central
Google Scholar
Tverdek FP, Rolston KV, Chemaly RF. Antimicrobial stewardship in patients with cancer. Pharmacotherapy. 2012;32:722–34.
Article
PubMed
Google Scholar
Klastersky J, Paesmans M, Rubenstein EB, et al. The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol. 2000;18:3038–51.
CAS
Article
PubMed
Google Scholar
Kern WV. Risk assessment and treatment of low-risk patients with febrile neutropenia. Clin Infect Dis. 2006;42:533–40.
Article
PubMed
Google Scholar
Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America. Clin Infect Dis. 2011;52:e56–93.
Article
PubMed
Google Scholar
Flowers CR, Seidenfeld J, Bow EJ, et al. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2013;31:794–810.
Article
PubMed
Google Scholar
Rolston KV. New trends in patient management: risk-based therapy for febrile patients with neutropenia. Clin Infect Dis. 1999;29:515–21.
CAS
Article
PubMed
Google Scholar
Virizuela JA, Carratalà J, Aguado JM, et al. Management of infection and febrile neutropenia in patients with solid cancer. Clin Transl Oncol. 2016;18:557–70.
CAS
Article
PubMed
Google Scholar
Rolston KV, Mihu C, Tarrand JJ. Current microbiology of percutaneous endoscopic gastrostomy tube (PEG tube) insertion site infections in patients with cancer. Support Care Cancer. 2011;19:1267–71.
Article
PubMed
Google Scholar
Abers MS, Sandvall BP, Sampath R, et al. Postobstructive pneumonia: an underdescribed syndrome. Clin Infect Dis. 2016;62:957–61.
Article
PubMed
Google Scholar
Rolston KV. Postobstructive pneumonia in cancer patients. Clin Infect Dis. 2016;63:707–8.
Article
PubMed
Google Scholar
Bin Nafisah S, Ahmad M. Ommaya reservoir infection rate: a 6-year retrospective cohort study of Ommaya reservoir in pediatrics. Childs Nerv Syst. 2015;31:29–36.
Article
PubMed
Google Scholar
Bahu R, Chaftari AM, Hachem RY, et al. Nephrostomy tube related pyelonephritis in patients with cancer: epidemiology, infection rate and risk factors. J Urol. 2013;189:130–5.
Article
PubMed
Google Scholar
Rolston KV, Nesher L, Tarrand JT. Current microbiology of surgical site infections in patients with cancer: a retrospective review. Infect Dis Ther. 2014;3:245–56.
Article
PubMed
PubMed Central
Google Scholar
Marín M, Gudiol C, Garcia-Vidal C, Ardanuy C, Carratalà J. Bloodstream infections in patients with solid tumors: epidemiology, antibiotic therapy, and outcomes in 528 episodes in a single cancer center. Medicine (Baltimore). 2014;93:143–9.
Article
Google Scholar
Rolston KV. The spectrum of pulmonary infections in cancer patients. Curr Opin Oncol. 2001;13:218–23.
CAS
Article
PubMed
Google Scholar
Badgwell BD, Cormier JN, Wray CJ, et al. Challenges in surgical management of abdominal pain in the neutropenic cancer patient. Ann Surg. 2008;248:104–9.
Article
PubMed
Google Scholar
Yapici O, Gunseren F, Yapici H, Merdin A, Yaylali Ü, Merdin FA. Evaluation of febrile neutropenic episodes in adult patients with solid tumors. Mol Clin Oncol. 2016;4:379–82.
PubMed
Google Scholar
Marin M, Gudiol C, Ardanuy C, et al. Bloodstream infections in neutropenic patients with cancer: differences between patients with haematological malignancies and solid tumours. J Infect. 2014;69:417–23.
Article
PubMed
Google Scholar
Rolston KV, Kontoyiannis DP, Yadegarynia D, Raad II. Nonfermentative gram-negative bacilli in cancer patients: increasing frequency of infection and antimicrobial susceptibility of clinical isolates to fluoroquinolones. Diagn Microbiol Infect Dis. 2005;51:215–8.
CAS
Article
PubMed
Google Scholar
Torres A, Ferrer M. Editorial Commentary: Distinguishing postobstructive lung infection from community-acquired pneumonia. Clin Infect Dis. 2016;62:962–3.
Article
PubMed
Google Scholar
Hsu-Kim C, Hoag JB, Cheng GS, Lund ME. The microbiology of postobstructive pneumonia in lung cancer patients. J Bronchol Interv Pulmonol. 2013;20:266–70.
Article
Google Scholar
Rolston KV, Bodey GP, Safdar A. Polymicrobial infection in patients with cancer: an underappreciated and underreported entity. Clin Infect Dis. 2007;45:228–33.
Article
PubMed
Google Scholar
Quint LE. Thoracic complications and emergencies in oncologic patients. Cancer Imaging. 2009;9(Spec No A):S75–82.
Article
PubMed
PubMed Central
Google Scholar
de Aquino Gorayeb MM, Gregório MG, de Oliveira EQ, Aisen S, Carvalho HA. High-dose-rate brachytherapy in symptom palliation due to malignant endobronchial obstruction: a quantitative assessment. Brachytherapy. 2013;12:471–8.
Article
PubMed
Google Scholar
Barr SP, Topps AR, Barnes NL, et al. Infection prevention in breast implant surgery—a review of the surgical evidence, guidelines and a checklist. Eur J Surg Oncol. 2016;42:591–603.
CAS
Article
PubMed
Google Scholar
Brand JS, Colzani E, Johansson AL, et al. Infection-related hospitalizations in breast cancer patients: risk and impact on prognosis. J Infect. 2016;72:650–8.
Article
PubMed
Google Scholar
Quinn TT, Miller GS, Rostek M, Cabalag MS, Rozen WM, Hunter-Smith DJ. Prosthetic breast reconstruction: indications and update. Gland Surg. 2016;5:174–86.
PubMed
PubMed Central
Google Scholar
Nahabedian MY, Tsangaris T, Momen B, Manson PN. Infectious complications following breast reconstruction with expanders and implants. Plast Reconstr Surg. 2003;112:467–76.
Article
PubMed
Google Scholar
Cordeiro PG, McCarthy CM. A single surgeon’s 12-year experience with tissue expander/implant breast reconstruction: part II. An analysis of long-term complications, aesthetic outcomes, and patient satisfaction. Plast Reconstr Surg. 2006;118:832–9.
CAS
Article
PubMed
Google Scholar
Francis SH, Ruberg RL, Stevenson KB, et al. Independent risk factors for infection in tissue expander breast reconstruction. Plast Reconstr Surg. 2009;124:1790–6.
CAS
Article
PubMed
Google Scholar
Cordeiro PG, Pusic AL, Disa JJ, McCormick B, VanZee K. Irradiation after immediate tissue expander/implant breast reconstruction: outcomes, complications, aesthetic results, and satisfaction among 156 patients. Plast Reconstr Surg. 2004;113:877–81.
Article
PubMed
Google Scholar
Epstein M, Silverstein M, Lin K, et al. Acute and chronic complications in breast cancer patients treated with intraoperative radiation therapy. Ann Surg Oncol. 2016;23:3304–9.
Article
PubMed
Google Scholar
Huo J, Smith BD, Giordano SH, Reece GP, Shih YC. Post-mastectomy breast reconstruction and its subsequent complications: a comparison between obese and non-obese women with breast cancer. Breast Cancer Res Treat. 2016;157:373–83.
Article
PubMed
Google Scholar
Seng P, Bayle S, Alliez A, Romain F, Casanova D, Stein A. The microbial epidemiology of breast implant infections in a regional referral centre for plastic and reconstructive surgery in the south of France. Int J Infect Dis. 2015;35:62–6.
Article
PubMed
Google Scholar
Rolston KV, Nesher L, Tarrand JT. Current microbiology of surgical site infections in patients with cancer: a retrospective review. Infect Dis Ther. 2014;3:245–256.
McCullough MC, Chu CK, Duggal CS, Losken A, Carlson GW. Antibiotic prophylaxis and resistance in surgical site infection after immediate tissue expander reconstruction of the breast. Ann Plast Surg. 2014;73:1–5.
Viola GM, Raad II, Rolston KV. Breast tissue expander-related infections: perioperative antimicrobial regimens. Infect Control Hosp Epidemiol. 2014;35:75–81.
Article
PubMed
Google Scholar
Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR, Guideline for Prevention of Surgical Site Infection. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control. 1999;1999(27):97–132.
Article
Google Scholar
Feldman EM, Kontoyiannis DP, Sharabi SE, Lee E, Kaufman Y, Heller L. Breast implant infections: is cefazolin enough? Plast Reconstr Surg. 2010;126:779–85.
CAS
Article
PubMed
Google Scholar
Ariyan S, Martin J, Lal A, et al. Antibiotic prophylaxis for preventing surgical-site infection in plastic surgery: an evidence-based consensus conference statement from the American Association of Plastic Surgeons. Plast Reconstr Surg. 2015;135:1723–39.
CAS
Article
PubMed
Google Scholar
Phillips BT, Bishawi M, Dagum AB, Khan SU, Bui DT. A systematic review of antibiotic use and infection in breast reconstruction: what is the evidence? Plast Reconstr Surg. 2013;131:1–13.
CAS
Article
PubMed
Google Scholar
Viola GM, Baumann DP, Mohan K, et al. Improving antimicrobial regimens for the treatment of breast tissue expander-related infections. Plast Reconstr Surg Glob Open. 2016;4:e704.
Article
PubMed
PubMed Central
Google Scholar
Viola GM, Selber JC, Crosby M, et al. Salvaging the infected breast tissue expander: a standardized multidisciplinary approach. Plast Reconstr Surg Glob Open. 2016;4:e732.
Article
PubMed
PubMed Central
Google Scholar
Cohen JB, Carroll C, Tenenbaum MM, Myckatyn TM. Breast implant-associated infections: the role of the national surgical quality improvement program and the local microbiome. Plast Reconstr Surg. 2015;136:921–9.
CAS
Article
PubMed
Google Scholar
Weichman KE, Levine SM, Wilson SC, Choi M, Karp NS. Antibiotic selection for the treatment of infectious complications of implant-based breast reconstruction. Ann Plast Surg. 2013;71:140–3.
CAS
Article
PubMed
Google Scholar
Huang SY, Philip A, Richter MD, Gupta S, Lessne ML, Kim CY. Prevention and management of infectious complications of percutaneous interventions. Semin Interv Radiol. 2015;32:78–88.
Article
Google Scholar
Shi S, Xia W, Guo H, Kong H, Zheng S. Unique characteristics of pyogenic liver abscesses of biliary origin. Surgery. 2016;159:1316–24.
Article
PubMed
Google Scholar
Sun Z, Li G, Ai X, et al. Hepatic and biliary damage after transarterial chemoembolization for malignant hepatic tumors: incidence, diagnosis, treatment, outcome and mechanism. Crit Rev Oncol Hematol. 2011;79:164–74.
Article
PubMed
Google Scholar
Shin JU, Kim KM, Shin SW, et al. A prediction model for liver abscess developing after transarterial chemoembolization in patients with hepatocellular carcinoma. Dig Liver Dis. 2014;46:813–7.
Article
PubMed
Google Scholar
Rolston KV, Dholakia N, Rodriguez S, Rubenstein EB. Nature and outcome of febrile episodes in patients with pancreatic and hepatobiliary cancer. Support Care Cancer. 1995;3:414–7.
CAS
Article
PubMed
Google Scholar
Xu C, Lv PH, Huang XE, Wang SX, Sun L, Wang FA. Analysis of different ways of drainage for obstructive jaundice caused by hilar cholangiocarcinoma. Asian Pac J Cancer Prev. 2014;15:5617–20.
Article
PubMed
Google Scholar
Sugiyama G, Okabe Y, Ishida Y, et al. Evaluation of endoscopic biliary stenting for obstructive jaundice caused by hepatocellular carcinoma. World J Gastroenterol. 2014;20:6968–73.
Article
PubMed
PubMed Central
Google Scholar
Schneider J, Hapfelmeier A, Fremd J, et al. Biliary endoprosthesis: a prospective analysis of bacterial colonization and risk factors for sludge formation. PLoS ONE. 2014;9:e110112.
Article
PubMed
PubMed Central
Google Scholar
Fujii T, Yamada S, Suenaga M, et al. Preoperative internal biliary drainage increases the risk of bile juice infection and pancreatic fistula after pancreatoduodenectomy: a prospective observational study. Pancreas. 2015;44:465–70.
Article
PubMed
Google Scholar
Gorschlüter M, Marklein G, Höfling K, et al. Abdominal infections in patients with acute leukaemia: a prospective study applying ultrasonography and microbiology. Br J Haematol. 2002;117:351–8.
Article
PubMed
Google Scholar
Capria S, Vitolo D, Cartoni C, et al. Neutropenic enterocolitis in acute leukemia: diagnostic and therapeutic dilemma. Ann Hematol. 2004;83:195–7.
CAS
Article
PubMed
Google Scholar
Nesher L, Rolston KVI. Neutropenic enterocolitis, a growing concern in the era of widespread use of aggressive chemotherapy. Clin Infect Dis. 2013;56:711–7.
Article
PubMed
Google Scholar
Ibrahim NK, Sahin AA, Dubrow RA, et al. Colitis associated with docetaxel-based chemotherapy in patients with metastatic breast cancer. Lancet. 2000;355:281–3.
CAS
Article
PubMed
Google Scholar
Kreis W, Petrylak D, Savarese D, Budman D. Colitis and docetaxel-based chemotherapy. Lancet. 2000;355:2164.
CAS
Article
PubMed
Google Scholar
de Matteis A, Nuzzo F, Rossi E, Landi G, Perrone F. Intestinal side-effects of docetaxel/vinorelbine combination. Lancet. 2000;355:1098–9.
Article
PubMed
Google Scholar
Kirkpatrick ID, Greenberg HM. Gastrointestinal complications in the neutropenic patient: characterization and differentiation with abdominal CT. Radiology. 2003;226:668–74.
Article
PubMed
Google Scholar
Cartoni C, Dragoni F, Micozzi A, et al. Neutropenic enterocolitis in patients with acute leukemia: prognostic significance of bowel wall thickening detected by ultrasonography. J Clin Oncol. 2001;19:756–61.
CAS
Article
PubMed
Google Scholar
Loo VG, Bourgault AM, Poirier L, et al. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med. 2011;365:1693–703.
CAS
Article
PubMed
Google Scholar
Emoto M, Kawarabayashi T, Hachisuga MD, Eguchi F, Shirakawa K. Clostridium difficile colitis associated with cisplatin-based chemotherapy in ovarian cancer patients. Gynecol Oncol. 1996;61:369–72.
CAS
Article
PubMed
Google Scholar
Allen VA, Manahan KJ, Geisler JP. Recurrent pseudomembranous colitis in an ovarian cancer patient undergoing carboplatin chemotherapy. Case Rep Obstet Gynecol. 2016;2016:7540302.
PubMed
PubMed Central
Google Scholar
Penziner S, Dubrovskaya Y, Press R, Safdar A. Fidaxomicin therapy in critically ill patients with Clostridium difficile infection. Antimicrob Agents Chemother. 2015;59:1776–81.
Article
PubMed
PubMed Central
Google Scholar
Cornely OA, Nathwani D, Ivanescu C, Odufowora-Sita O, Retsa P, Odeyemi IA. Clinical efficacy of fidaxomicin compared with vancomycin and metronidazole in Clostridium difficile infections: a meta-analysis and indirect treatment comparison. J Antimicrob Chemother. 2014;69:2892–900.
CAS
Article
PubMed
Google Scholar
Zhanel GG, Walkty AJ, Karlowsky JA. Fidaxomicin: a novel agent for the treatment of Clostridium difficile infection. Can J Infect Dis Med Microbiol. 2015;26:305–12.
PubMed
PubMed Central
Google Scholar
Kelly CR, Khoruts A, Staley C, et al. Effect of fecal microbiota transplantation on recurrence in multiply recurrent Clostridium difficile infection: a randomized trial. Ann Intern Med. 2016;165:609–616.
Schlick K, Grundbichler M, Auberger J, et al. Cytomegalovirus reactivation and its clinical impact in patients with solid tumors. Infect Agent Cancer. 2015;10:45.
Article
PubMed
PubMed Central
Google Scholar
Torres HA, Kontoyiannis DP, Bodey GP, et al. Gastrointestinal cytomegalovirus disease in patients with cancer: a two decade experience in a tertiary care cancer center. Eur J Cancer. 2005;41:2268–79.
Article
PubMed
Google Scholar
Alter MJ. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol. 2006;44:S6–9.
Article
PubMed
Google Scholar
Wasley A, Kruszon-Moran D, Kuhnert W, et al. The prevalence of hepatitis B virus infection in the United States in the era of vaccination. J Infect Dis. 2010;202:192–201.
Article
PubMed
Google Scholar
Averhoff FM, Glass N, Holtzman D. Global burden of hepatitis C: considerations for healthcare providers in the United States. Clin Infect Dis. 2012;55(Suppl 1):S10–5.
Article
PubMed
Google Scholar
Hwang JP, Somerfield MR, Alston-Johnson DE, et al. Hepatitis B virus screening for patients with cancer before therapy: American Society of Clinical Oncology provisional clinical opinion update. J Clin Oncol. 2015;33:2212–20.
Article
PubMed
PubMed Central
Google Scholar
Shouval D, Shibolet O. Immunosuppression and HBV reactivation. Semin Liver Dis. 2013;33:167–77.
CAS
Article
PubMed
Google Scholar
Weinbaum CM, Williams I, Mast EE, et al. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep. 2008;57:1–20.
PubMed
Google Scholar
Paul S, Saxena A, Terrin N, Viveiros K, Balk EM, Wong JB. Hepatitis B virus reactivation and prophylaxis during solid tumor chemotherapy: a systematic review and meta-analysis. Ann Intern Med. 2016;164:30–40.
Article
PubMed
Google Scholar
Hwang JP, Barbo AG, Perrillo RP. Hepatitis B reactivation during cancer chemotherapy: an international survey of the membership of the American Association for the Study of Liver Diseases. J Viral Hepat. 2015;22:346–52.
CAS
Article
PubMed
Google Scholar
Hwang JP, Vierling JM, Zelenetz AD, Lackey SC, Loomba R. Hepatitis B virus management to prevent reactivation after chemotherapy: a review. Support Care Cancer. 2012;20:2999–3008.
Article
PubMed
PubMed Central
Google Scholar
Baden LR, Swaminathan S, Angarone M, et al. Prevention and treatment of cancer-related infections, version 2.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw. 2016;14:882–913.
CAS
Google Scholar
Torres HA, Mahale P, Blechacz B, et al. Effect of hepatitis C virus infection in patients with cancer: addressing a neglected population. J Natl Compr Cancer Netw. 2015;13:41–50.
Google Scholar
Mahale P, Kontoyiannis DP, Chemaly RF, et al. Acute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients. J Hepatol. 2012;57:1177–85.
Article
PubMed
Google Scholar
Borchardt RA, Torres HA. Challenges in managing hepatitis C virus infection in cancer patients. World J Gastroenterol. 2014;20:2771–6.
Article
PubMed
PubMed Central
Google Scholar
Lee MH, Yang HI, Yuan Y, L’Italien G, Chen CJ. Epidemiology and natural history of hepatitis C virus infection. World J Gastroenterol. 2014;20:9270–80.
PubMed
PubMed Central
Google Scholar
Yazici O, Sendur MA, Aksoy S. Hepatitis C virus reactivation in cancer patients in the era of targeted therapies. World J Gastroenterol. 2014;20:6716–24.
Article
PubMed
PubMed Central
Google Scholar
Butt AA, Wang X, Moore CG. Effect of hepatitis C virus and its treatment on survival. Hepatology. 2009;50:387–92.
Article
PubMed
Google Scholar
Mira JA, Rivero-Juárez A, López-Cortés LF, et al. Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV/hepatitis C virus-coinfected patients with compensated cirrhosis. Clin Infect Dis. 2013;56:1646–53.
CAS
Article
PubMed
Google Scholar
Flukes S, Hayne D, Kuan M, Wallace M, McMillan K, Rukin NJ. Retrograde ureteric stent insertion in the management of infected obstructed kidneys. BJU Int. 2015;115(Suppl 5):31–4.
Article
PubMed
Google Scholar
Benson AD, Taylor ER, Schwartz BF. Metal ureteral stent for benign and malignant ureteral obstruction. J Urol. 2011;185:2217–22.
Article
PubMed
Google Scholar
Goldsmith ZG, Wang AJ, Bañez LL, et al. Outcomes of metallic stents for malignant ureteral obstruction. J Urol. 2012;188:851–5.
Article
PubMed
Google Scholar
de Naurois J, Novitzky-Basso I, Gill MJ, et al. Management of febrile neutropenia: ESMO Clinical Practice Guidelines. Ann Oncol. 2010;21(Suppl 5):v252–6.
Article
PubMed
Google Scholar